Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

New Member of Endothelial Arsenal Against Inflammation

Walter N. Durán, Fabiola A. Sánchez
Download PDF
https://doi.org/10.1161/CIRCRESAHA.116.309122
Circulation Research. 2016;119:178-180
Originally published July 7, 2016
Walter N. Durán
From the Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ (W.N.D.); and Instituto de Inmunología, Escuela de Medicina, Universidad Austral de Chile, Valdivia, Chile (F.A.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiola A. Sánchez
From the Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ (W.N.D.); and Instituto de Inmunología, Escuela de Medicina, Universidad Austral de Chile, Valdivia, Chile (F.A.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • Editorials
  • 5-methoxytryptophan
  • capillary permeability
  • endothelium
  • inflammation

The endothelium evolved from a conceptual cellophane-like structure involved in blood–tissue exchange of solutes to an active set of vascular cells with a diverse and broad array of functions in health and disease.1,2 Because of its strategic immediate contact with blood and tissues, the endothelium regulates transport barrier properties, contributes to control of blood flow, prevents hemorrhage through fine tuning of platelet adhesion, and is an important player in controlling immunologic responses. Several articles and reviews have pointed out that endothelial dysfunction is the fundamental basis of inflammation and vascular disease.3–6

Article, see p 222

Research in vascular biology has identified several key endothelial proteins along with factors that cause the onset of inflammation. Tissue necrosis factor-α is a major cytokine that activates endothelial cells and promotes inflammation. Proteins involved in regulatory functions include intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and vascular endothelial cadherin. Intercellular adhesion molecule-1-1 and vascular cell adhesion molecule-1-1 play an important role in adhesion and migration of leukocytes in inflammation,7 whereas vascular endothelial cadherin participates in the regulation of microvascular transport.8,9

The proteins mentioned in the preceding paragraph, as well as the proteins that serve as coagulation factors, are largely located on the cell membrane and exert their main function by reacting to external stimuli. Interest in the biology of endothelial cells was immensely enhanced by the realization that they produce endogenous factors, leading to signaling cascades that control vascular function at the cellular and organ levels. Endothelium-derived relaxing factor, subsequently identified as nitric oxide (NO), is the most revolutionary among these endogenous factors.10–14 Indeed, deficit in NO availability is considered as a clinical sign for endothelial dysfunction.15 NO derived from endothelial NO synthase (eNOS) serves as the main signal for vasodilation in vascular smooth muscle. Importantly, an endogenous function (in regard to endothelium) of eNOS-derived NO is to serve as a fundamental signal for the onset of hyperpermeability in response to inflammatory agents, a function implemented mainly via S-nitrosylation, that is, binding of NO· to cysteine.9,16,17 Prostacyclin, endothelin, carbon monoxide, and endothelial-hyperpolarizing factor share with NO the vascular function of controlling blood flow. Prostacyclin, or at least its analog iloprost, has been linked to the function of restoring microvascular permeability after inflammation-induced hyperpermeability.18,19 Because they regulate the vascular functions of tissue perfusion and blood–tissue transport, all the endothelium-derived molecules play a significant role in the response to inflammatory stimuli.

Wang et al20 add a new molecule of endothelial origin as an anti-inflammatory agent in their article in this issue of Circulation Research. The authors extracted and identified 5-methoxytryptophan (5-MTP) from endothelial cell–conditioned medium. Although it is known that other cells make 5-MTP, one of the merits of the work by Wang et al20 is the demonstration that endothelial cells produce 5-MTP. They conducted a series of logically designed experiments to ascertain the role of 5-MTP in inflammation using accepted in vitro and in vivo models of endotoxemia (lipopolysaccharide, in vitro—human umbilical vein endothelial cells) and sepsis (cecal ligation and puncture, in vivo—in mice), as well as in a translational manner in patients. Overall, the results support the authors’ main conclusion that 5-MTP plays a role as an anti-inflammatory agent.

Wang et al20 showed the translational potential of the their research through results revealing a decrease in 5-MTP concentration in the blood of septic patients, which suggest that an increase in 5-MTP may yield benefits to improve health. Through comparison of 5-MTP concentrations in the blood of different groups of patients, the authors concluded that 5-MTP is a marker of systemic inflammation—but it does not report the stage of progression of sepsis. Wang et al20 tested in vivo whether administration of exogenous 5-MTP prevents lipopolysaccharide-induced extravasation of albumin in mouse lungs. Although the results are encouraging, the mechanisms through which 5-MTP prevents pulmonary hyperpermeability to proteins remain to be determined. The authors tested microvascular permeability using an all or none approach. A combination of more sophisticated intravital (in vivo) methods and cultured endothelial cells should provide mechanistic insights to explain the beneficial actions of 5-MTP. Similarly, it will be important to assess whether 5-MTP can reverse extravasation of macromolecules induced by inflammatory processes.

Wang et al20 evaluated the source of 5-MTP by immunohistochemistry and found it to be associated with endothelium and vascular smooth muscle. Appropriately, the authors tested the endothelial presence of 5-MTP in vivo in the lung, a tissue endowed with high microvascular endothelial mass, in addition to testing for its presence in aorta. This observation is significant inasmuch as human umbilical vein endothelial cell and aorta represent endothelial cells derived from large vessels and may incompletely recapitulate the behavior of microvascular endothelial cells. The presence of 5-MTP in conduit large vessels and in microvessels suggests that this chemical may be an element of endothelial defense against several inflammatory vascular diseases; some of which may be manifested primarily in large vessels (atherosclerosis) and others that have deep roots in the microcirculation (hypertension and diabetes mellitus) where the regulation of blood flow and microvascular permeability resides.

In terms of future directions, this report20 opens the door for investigations of the specific stimuli leading to production of 5-MTP, the cellular mechanisms of action of 5-MTP, and the pathways through which it is exported. Because the authors determined the location of 5-MTP in the cytoplasm and because eNOS translocation from the cell membrane to the cytosol is a requirement for the development of hyperpermeability,21–24 it is tempting to speculate that 5-MTP may reduce the transport of macromolecules across microvascular walls by returning eNOS from the cytoplasm to the cell membrane or by inhibiting the synthesis of eNOS-derived NO in the cytoplasm.

Figure 1 shows a simplified account of pro- and anti-inflammatory mediators acting on the vasculature. The state of our understanding of the factors that play a role in vascular inflammation has been the subject of extensive reviews.5,25 The balance of our knowledge shows the predominance of proinflammatory agents and relative paucity of endothelial anti-inflammatory molecules. The report by Wang et al20 rekindles the interest in identifying and exploring regulatory factors produced by endothelial and vascular cells.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Simplified scheme displaying a selection of representative pro- and anti-inflammatory molecules. Several cells and plasma-based biochemical reactions produce an abundance of proinflammatory molecules. Endothelial cells (ECs) counteract inflammation through synthesis of anti-inflammatory factors. Cytoplasmic nitric oxide (NO) synthase (eNOS)–NO functions as proinflammatory mediator, whereas caveolar-cell membrane eNOS–NO functions as an anti-inflammatory molecule. 5-methoxytryptophan (5-MTP), which is found in EC and in vascular smooth muscle cells, joins the EC anti-inflammatory arsenal. The swing position is intended to stimulate further search for novel endothelial (vascular) anti-inflammatory molecules. IL indicates interleukin; PAF, platelet-activating factor; TNF-α, tumor necrosis factor-a; and VEGF, vascular endothelial growth factor.

Sources of Funding

The authors’ research was supported by National Heart, Lung, and Blood Institute Grants 5RO1-HL-070634 and 5RO1 HL-088479, and Fondecyt 1130769 (Chile).

Disclosures

None.

Footnotes

  • The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

  • © 2016 American Heart Association, Inc.

References

  1. 1.↵
    1. Pappenheimer JR,
    2. Renkin EM,
    3. Borrero LM
    . Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability. Am J Physiol. 1951;167:13–46.
    OpenUrl
  2. 2.↵
    1. Shepro D
    . The American Microcirculatory Society Landis Award lecture. Endothelial cells, inflammatory edema, and the microvascular barrier: comments by a “free radical”. Microvasc Res. 1988;35:246–264.
    OpenUrlPubMed
  3. 3.↵
    1. Cook-Mills JM,
    2. Deem TL
    . Active participation of endothelial cells in inflammation. J Leukoc Biol. 2005;77:487–495. doi: 10.1189/jlb.0904554.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Durán WN,
    2. Dillon PK
    . Effects of ischemia-reperfusion injury on microvascular permeability in skeletal muscle. Microcirc Endothelium Lymphatics. 1989;5:223–239.
    OpenUrlPubMed
  5. 5.↵
    1. Pober JS,
    2. Sessa WC
    . Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–815. doi: 10.1038/nri2171.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Szmitko PE,
    2. Wang CH,
    3. Weisel RD,
    4. de Almeida JR,
    5. Anderson TJ,
    6. Verma S
    . New markers of inflammation and endothelial cell activation: Part I. Circulation. 2003;108:1917–1923. doi: 10.1161/01.CIR.0000089190.95415.9F.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Muller WA
    . Mechanisms of transendothelial migration of leukocytes. Circ Res. 2009;105:223–230. doi: 10.1161/CIRCRESAHA.109.200717.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Dejana E,
    2. Orsenigo F,
    3. Lampugnani MG
    . The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 2008;121:2115–2122. doi: 10.1242/jcs.017897.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Guequén A,
    2. Carrasco R,
    3. Zamorano P,
    4. Rebolledo L,
    5. Burboa P,
    6. Sarmiento J,
    7. Boric MP,
    8. Korayem A,
    9. Durán WN,
    10. Sánchez FA
    . S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability. Am J Physiol Heart Circ Physiol. 2016;310:H1039–H1044. doi: 10.1152/ajpheart.00063.2016.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Balabanli B,
    2. Kamisaki Y,
    3. Martin E,
    4. Murad F
    . Requirements for heme and thiols for the nonenzymatic modification of nitrotyrosine. Proc Natl Acad Sci U S A. 1999;96:13136–13141.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Furchgott RF,
    2. Zawadzki JV
    . The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Murad F
    . Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res. 1999;32:1317–1327.
    OpenUrlPubMed
  13. 13.↵
    1. Murad F
    . Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep. 1999;19:133–154.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Taylor CT,
    2. Moncada S
    . Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol. 2010;30:643–647. doi: 10.1161/ATVBAHA.108.181628.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Beckman JA,
    2. Liao JK,
    3. Hurley S,
    4. Garrett LA,
    5. Chui D,
    6. Mitra D,
    7. Creager MA
    . Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res. 2004;95:217–223. doi: 10.1161/01.RES.0000134628.96682.9b.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Marín N,
    2. Zamorano P,
    3. Carrasco R,
    4. Mujica P,
    5. González FG,
    6. Quezada C,
    7. Meininger CJ,
    8. Boric MP,
    9. Durán WN,
    10. Sánchez FA
    . S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability. Circ Res. 2012;111:553–563. doi: 10.1161/CIRCRESAHA.112.274548.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Thibeault S,
    2. Rautureau Y,
    3. Oubaha M,
    4. Faubert D,
    5. Wilkes BC,
    6. Delisle C,
    7. Gratton JP
    . S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell. 2010;39:468–476. doi: 10.1016/j.molcel.2010.07.013.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Birukova AA,
    2. Wu T,
    3. Tian Y,
    4. Meliton A,
    5. Sarich N,
    6. Tian X,
    7. Leff A,
    8. Birukov KG
    . Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury. Eur Respir J. 2013;41:165–176. doi: 10.1183/09031936.00148311.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Blebea J,
    2. Cambria RA,
    3. DeFouw D,
    4. Feinberg RN,
    5. Hobson RW 2nd.,
    6. Duran WN
    . Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J Vasc Surg. 1990;12:657–665. doi: 10.1067/mva.1990.25129.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Wang YF,
    2. Hsu YJ,
    3. Wu HF,
    4. Lee GL,
    5. Yang YS,
    6. Wu JY,
    7. Yet SF,
    8. Wu KK,
    9. Kuo CC
    . Endothelium-derived 5-methoxytryptophan is a circulating anti-inflammatory molecule that blocks systemic inflammation. Circ Res. 2016;119:222–236. doi: 10.1161/CIRCRESAHA.116.308559.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Durán WN,
    2. Beuve AV,
    3. Sánchez FA
    . Nitric oxide, S-nitrosation, and endothelial permeability. IUBMB Life. 2013;65:819–826. doi: 10.1002/iub.1204.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Sánchez FA,
    2. Kim DD,
    3. Durán RG,
    4. Meininger CJ,
    5. Durán WN
    . Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. Am J Physiol Heart Circ Physiol. 2008;295:H1642–H1648. doi: 10.1152/ajpheart.00629.2008.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Sánchez FA,
    2. Rana R,
    3. González FG,
    4. Iwahashi T,
    5. Durán RG,
    6. Fulton DJ,
    7. Beuve AV,
    8. Kim DD,
    9. Durán WN
    . Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. J Biol Chem. 2011;286:30409–30414. doi: 10.1074/jbc.M111.234294.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Sánchez FA,
    2. Rana R,
    3. Kim DD,
    4. Iwahashi T,
    5. Zheng R,
    6. Lal BK,
    7. Gordon DM,
    8. Meininger CJ,
    9. Durán WN
    . Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. Proc Natl Acad Sci U S A. 2009;106:6849–6853. doi: 10.1073/pnas.0812694106.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Tedgui A,
    2. Mallat Z
    . Anti-inflammatory mechanisms in the vascular wall. Circ Res. 2001;88:877–887.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
July 8, 2016, Volume 119, Issue 2
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    New Member of Endothelial Arsenal Against Inflammation
    Walter N. Durán and Fabiola A. Sánchez
    Circulation Research. 2016;119:178-180, originally published July 7, 2016
    https://doi.org/10.1161/CIRCRESAHA.116.309122

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    New Member of Endothelial Arsenal Against Inflammation
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    New Member of Endothelial Arsenal Against Inflammation
    Walter N. Durán and Fabiola A. Sánchez
    Circulation Research. 2016;119:178-180, originally published July 7, 2016
    https://doi.org/10.1161/CIRCRESAHA.116.309122
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured